Dr. Reddy's Research Foundation

Reddy-cheminor, Inc.

Other

Dr. Reddy's Laboratories, Incorporated

Reddy's Laboratories Ltd.

Redd's Research Foundation

Reddy's Research Foundation

Dr. Reddy's Laboraties Limited

Braj Bhushan Lohray

Vidya Bhushan Lohray

Rajagopalan Ramanujam

Ranjan Chakrabarti

Rao Bheema Paraselli

Ranga Madhavan Gurram

Shivaramayya Kalchar

Ashok Channaveerappa Bajji

Sekar Reddy Alla

Venkateswarlu Akella

Ashok Bajji

Sarma K S Pakala

Javed Iqbal

Parimal Misra

Jagattaran Das

Sitaram Kumar Magadi

Reeba Kannimel Vikramadithyan

Srinivasa Rao Naga Venkata Mamidi

Baskaran Sundarababu

Sarma Ks Pakala

Ashok Chennaveerappa Bajji

Selvakumar Natesan

Saibal Kumar Das

Ramanujam Rajagopalan

Prem Kumar Mamnoor

Chakrabarti Ranjan

Papi Reddy Purma

Narayan Reddy Kommireddi

Prasuna Guntupalli

Sarma K Pakala

Paraselli Bheema Rao

The present invention relates to novel antiobesity and hypocholesterolemic compounds, their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. More particularly, the present invention relates to novel &#x3b2;-aryl-&#x3b1;-oxysubstituted alkylcarboxylic acids of general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them 

Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents

The present invention relates to novel oxazolidinone compounds of the general formula (I). where R, R, R, Y, Y, Y, and Z are as defined in the description; their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutical compositions containing them.

Heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them

The present invention relates to novel antiobesity and hypocholesterolemic compounds, their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. More particularly, the present invention relates to novel &#x3b2;-aryl-&#x3b1;-oxysubstituted alkylcarboxylic acids of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. The present invention also relates to a process for the preparation of the above said novel compounds, their analogs, their derivatives, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them. The present invention also relates to novel intermediates, processes for their preparation and their use in the preparation of compounds of formula (I).

Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them

Novel &#x3b2;-aryl-&#x3b1;-oxysubstituted alkylcarboxylic acids of the formula (I) and compositions containing them.  The compounds have hypolipidemic, antihyperglycemic uses.

Tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them

The present invention relates to novel antidiabetic compounds, their tautomeric forms, their derivatives, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. This invention particularly relates to novel azolidinedione derivatives of the general formula (I), and their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them.

Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases

The present invention relates to novel oxazolidinone compounds of the general formula (I)where R, R, R, Y, Y, Y, and Z are as defined in the description; their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutical acceptable salts, their pharmaceutically acceptable solvates and pharmaceutical compositions containing them.

Novel &#x3b2;-aryl-&#x3b1;-oxysubstituted alkylcarboxylic acids of the formula (I) and compositions containing them.The compounds have hypolipidemic, antihyperglycemic uses.

Tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them

Compounds of formula (I)its tautomeric forms, its stereoisomers, its polymorphs, its pharmaceutically acceptable salts or its pharmaceutically acceptable solvates can be used to prevent or treat diabetes caused by insulin resistance or impaired glucose tolerance or complications of diabetes caused by insulin resistance or impaired glucose tolerance. The compounds can also be used to reduce cholesterol, body weight, blood glucose, triglycerides and free fatty acids in the blood.

Bicyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them

Heterocyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them

Growing community of inventors

Hyderabad Telangana, India

Braj Bhushan Lohray